Compounds > stanozolol
Page last updated: 2024-08-22

stanozolol and Diabetes Mellitus, Type 2

stanozolol has been researched along with Diabetes Mellitus, Type 2 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kluft, C; Lowe, GD; MacCuish, AC; Small, M1
Forbes, CD; MacCuish, AC; Small, M1
Forbes, CD; Lowe, GD; MacCuish, AC; Small, M1

Other Studies

3 other study(ies) available for stanozolol and Diabetes Mellitus, Type 2

ArticleYear
Tissue plasminogen activator inhibition in diabetes mellitus.
    Diabetes care, 1989, Volume: 12, Issue:9

    Topics: Antibodies, Monoclonal; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Kinetics; Male; Middle Aged; Plasminogen Inactivators; Stanozolol; Tissue Plasminogen Activator

1989
Metabolic effects of stanozolol in type II diabetes mellitus.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1986, Volume: 18, Issue:9

    Topics: Adult; Aged; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Stanozolol; Triglycerides

1986
The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.
    Thrombosis research, 1986, Oct-15, Volume: 44, Issue:2

    Topics: Administration, Oral; Adult; Aged; alpha-2-Antiplasmin; Diabetes Mellitus, Type 2; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Plasminogen; Research Design; Stanozolol

1986